VERALLIA Shares Up 4.04% at Midday
This Wednesday midday, Verallia slightly moves ahead, with the glass container manufacturer's stock increasing by 4.04% to €23.16. Despite this intraday rebound, the stock remains significantly weakened in the long term, showing a decline of 17.58% since the start of 2025. Trading remains sluggish, with only 0.02% of the capital traded during the session, indicating limited activity around the stock.
Short-Term Context Remains Lackluster for Verallia
The short-term context remains lackluster for Verallia. Over a week, the stock is almost stable with a minor decrease of 0.17%, while over three months, the situation significantly worsens with a drop of 18.16%. The underperformance is particularly pronounced on an annual scale: over the past twelve months, Verallia has plunged by 17.58% while the CAC 40 has posted a positive performance of 8.82%. This morning's rebound remains isolated and occurs on extremely limited market volumes, raising questions about its sustainability. Technically, the stock is trading close to its 50-day moving average, set at €23.73, nearly at the current price level. Above, the major resistance is established at €23.96, only €0.80 above, forming a congested zone. Conversely, the main support is at €21.88, providing a cushion of about 5.4% below the current price. The stock is within a Bollinger band ranging from €21.73 to €23.98, positioning Verallia in the upper portion of its recent volatility. The 200-day moving average remains significantly higher, at €27.07, confirming the deterioration of the long-term dynamics.
Fundamental Context Remains Concerning
The fundamental context remains concerning. The results for the third quarter of 2025, communicated the day before yesterday, reveal a deterioration in the group's profitability. The quarter's revenue was set at 846 million euros, down 2.8% year-on-year. In organic growth, the erosion is nevertheless mitigated: it only reaches 0.6% in Q3 2025 compared to a drop of 4.7% in Q3 2024, marking a relative stabilization. However, it is the adjusted EBITDA that is worrying: it contracted to 180.6 million euros, from 210 million a year earlier, a drop of 13.9%. The group's operating margin compressed by 2.8 points, moving from 24.1% to 21.3%. Behind this deterioration lies a concerning mechanism: while volumes increased by 34 million euros, price pressure and product mix erosion weighed for 38.9 million euros, and currency effects burdened the result by 19.7 million euros. Over nine months, cumulative revenue reached 2,568.6 million euros compared to 2,635.2 million in 2024, a decrease of 2.5%. Net debt stands at 1,920.4 million euros, with a leverage ratio reaching 2.6 times the adjusted EBITDA of the last twelve months, marking a deterioration compared to the 2.3 times recorded at the same period in 2024.
Technical Indicators Reflect Mixed Signals
On the technical front, the Relative Strength Index (RSI) stands at 39, indicating no immediate overvaluation. The MACD paints a mixed picture: the line is positioned at -0.24, with the signal line at -0.25, producing an almost neutral histogram of +0.01, indicating a very slight bullish divergence without clear conviction. Capital flows from floating shares display a decidedly negative tone, with a CMF of -0.13, while the accumulation/distribution index is at -272,963, suggesting a total lack of accumulation by institutional participants. Monthly volatility remains contained at 6.61%, reflecting movements of low amplitude. Finally, the stock's beta of 0.08 indicates an almost total decorrelation with the market index, characteristic of a stock with specific dynamics.
